Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00405938
Status:
COMPLETED
Last Update Posted:
2021-11-18
First Post:
2006-11-28
Brief Title:
Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
Sponsor:
SCRI Development Innovations LLC
Organization:
SCRI Development Innovations LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-28
First Submit QC Date:
November 28 2006
Study First Post Date:
2006-11-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2013-02-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-16
Last Update Post Date:
2021-11-18
Last Update Post Date Type:
ACTUAL